Abstract:
The present invention is based in part on the discovery of a panel of miRs whose levels are increased or decreased in the circulation of chronic systolic HF patients. Accordingly, an extensive panel of miRs was screened in the sera of stable chronic systolic HF patients and the results were compared to an age, gender and ethnically matched control group.
Abstract:
Provided are isolated viral and human nucleic acids including microRNAs associated with different viral infection, including HSV1, HSV2, RSV, EBV, Influenza A, HIV, HPV, HIV, HBV, and Vaccinia viral infection. The disclosure further provides methods for detecting viral infection using the nucleic acids, and methods of inhibiting and treating viral infection using pharmaceutical composition comprising associated nucleic acids.
Abstract:
Described herein are compositions and methods for the prognosis of renal cancer patients after surgical operation. Specifically the invention relates to microRNA molecules associated with the prognosis of renal cancer, as well as various nucleic acid molecules relating thereto or derived therefrom.
Abstract:
Disclosed are microRNA molecules, as well as various nucleic acid molecules relating thereto or derived therefrom Further disclosed are methods and compositions that can be used for diagnosis of cancer.
Abstract:
The present invention relates to a first group of novel genes, here identified as "genomic address messenger" or "GAM" genes, and a second group of novel operon-like genes, here identified as "genomic record" or "GR" genes. GAM genes selectively inhibit translation of known 'target' genes, many of which are known to be involved in various diseases. Nucleic acid molecules are provided respectively encoding 20600 GAM genes, and 6635 GR genes, as are vectors and probes both comprising the nucleic acid molecules, and methods and systems for detecting GAM and GR genes and specific functions and utilities thereof, for detecting expression of GAM and GR genes, and for selectively enhancing and selectively inhibiting translation of the respective target genes thereof.
Abstract:
The present invention provides methods and compositions for identifying subjects at risk of developing a complication of pregnancy, such as preeclampsia or preterm labor. The compositions are microRNAs and associated nucleic acids.
Abstract:
The invention relates in general to microRNA molecules associated with glioblastoma, as well as various molecules relating thereto. More specifically, the invention relates to methods and compositions for the treatment of glioblastoma and for treatment by a combination of microRNA molecules and Imatinib mesylate.
Abstract:
The invention relates in general to microRNA molecules associated with glioblastoma, as well as various molecules relating thereto. More specifically, the invention relates to methods and compositions for the treatment of glioblastoma and for treatment by a combination of microRNA molecules and Imatinib mesylate.
Abstract:
The invention provides a method for conducting minimally-invasive early detection of colorectal cancer and/or of colorectal cancer precursor cells, by using microRNA molecules associated with colorectal cancer, as well as various nucleic acid molecules relating thereto or derived thereof.
Abstract:
The present invention provides a process for classification of specific cancers and tumors origin through the analysis of the expression patterns of specific microRNAs and nucleic acid molecules relating thereto. Classification according to a microRNA expression framework allows optimization of treatment, and determination of specific therapy.